2006 Chronic Disease Diabetes Individual 
Today's Hospitalist
JUNE 7, 2025
THE BLOCKBUSTER GLP-1 receptor agonists are a transformative class of medications increasingly tied to better outcomes across a variety of conditions and organ systems, not just in patients with obesity and type 2 diabetes. ” Phyllis Maguire has been Executive Editor of Today’s Hospitalist since 2006. Based in Bucks County, Pa.,
GeriPal
MAY 1, 2025
There was some at the time, which was 2006 so also, it’s been a while since the guidance has been updated and other guidance for other viral infections like hepatitis B and C. I mean, you know, you mentioned diabetes. Eric 26:39 But I’m also hearing that 1 out of 10 newly diagnosed cases are not those individuals.
Expert insights. Personalized for you.
66 
Let's personalize your content